Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Utilizing cutting-edge techniques and state-of-the-art facilities, Dr
see this practical GoodRx overview for context GoodRx explainer
This has been done for a small number of injectable medications (for example, certain specialty oncology drugs)
Meet our doctors Last reviewed: 19 Jun 2026 Sources Nevolat, EMC [accessed 20 February 2025] Obesity treatment, NHS [accessed 20 February 2025] Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen, EMC [accessed 20 February 2025] Mounjaro KwikPen 10mg solution for injection in pre-filled pen, EMC [accessed 20 February 2025] Once-Weekly Semaglutide in Adults with Overweight or Obesity, The New England Journal of Medicine [accessed 20 February 2025] Weight loss injections NHS weight loss injections GLP-1 for weight loss Can doctors help with weight loss
Pending a clinical assessment, Wegovy 7.2mg is a suitable treatment for patients aged 18 years and above who meet any of the following criteria: A BMI of 30 or above A BMI of 27 or above alongside a weight-related health condition such as prediabetes, high blood pressure or type 2 diabetes Its important to note that this treatment is most effective when combined with a balanced diet and regular physical activity
Unlike traditional single-pathway or dual-pathway incretin compounds, this molecule is structurally designed to activate GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously
